Anthropic has launched an initiative to accelerate scientific research using artificial intelligence (AI) models. To this end, the company is secretly establishing its own biological laboratory in the San Francisco Bay Area, California. Within this new facility, Anthropic is already training its proprietary Claude AI model to conduct diverse biological experiments. Through this pioneering effort, the firm is exploring the viability of automating specific stages of scientific research using AI models in the future.
Claude AI will assist in the design of scientific experiments in the laboratory, and the experiments will be performed through automation techniques using robots. Feedback from the results achieved from such an experiment will be utilized to enhance future designs to be more efficient.
Eric Kauderer-Abrams, the head of life sciences at Anthropic, says that some research has been performed by the company in its "wet lab," and they have been collaborating with other research institutions as well. But it should be noted that the research is not for any drug discovery process.
Anthropic did not make any claims that the Claude AI model will carry out all the lab experiments completely independent of any human involvement. Anthropic stressed the point that human involvement would continue to be critical considering the sensitivity of the biological experiments and the need for ensuring safety in the process; this implies that although AI and robots will be involved in different stages of the experiment, decision making will always lie with humans.
However, the company’s engagement in the use of AI for studying biology is in no way novel, since Anthropic had already made a plan to use AI in fast-tracking studies of diseases and complicated treatment programs. Particularly, it was highly interested in focusing on technology to help in researching rare diseases, which usually require a lot of time and money. Nonetheless, the company has not announced the exact field of study in the new laboratory setup.
